FDA Approves New Treatment for Hard-to-Treat Pancreatic Cancer

FDA approves new treatment for hard-to-treat pancreatic cancer

The U.S. Food and Drug Administration announced Wednesday the approval of a treatment for pancreatic cancer that could usher in a new era in managing one of the deadliest forms of the disease.

FDA approves breakthrough pancreatic cancer drug

The FDA has approved a new drug to treat pancreatic cancer. NPR's A Martinez speaks with Adam Feuerstein, who writes for the science and health website STAT.

FDA approves breakthrough drug daraxonrasib to treat pancreatic cancer

Experts have hailed the drug, daraxonrasib, as a game changer for one of the world's deadliest cancers.

Groundbreaking drug that targets deadly type of cancer clears hurdle

The Food and Drug Administration on Wednesday approved a groundbreaking new drug for advanced pancreatic cancer, offering U.S. patients a more effective treatment against one of the deadliest types of cancer.